“Israel’s BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes late-stage clinical trials….”
“The Bill and Melinda Gates Foundation has awarded a $4.7 million supplemental grant to a UC San Diego-led research consortium to develop therapies to eradicate malaria. The 3-year grant is led by Elizabeth Winzeler, professor in the pediatric division of host-microbe systems and therapeutics at UCSD School of Medicine…”
“Pfizer and Celltrion have unveiled Phase III study data comparable safety and efficacy between biosmilar Inflectra and reference drug Remicade in patients with moderate-to-severe Crohn’s disease (CD)…”
Engineered T cells, which aim to mount an immune response against cancer, are gaining steam in the immuno-oncology market, with Kite Pharma and Novartis racing to get their CAR-T therapies for blood cancers approved. But they don’t work for all patients, and researchers have struggled to find uses for them in solid tumors.